Boost Clinical Trial Recruitment & Retention with Zelthy

Patient recruitment and retention are the most common causes of clinical trial failure and delay. Nearly 80% of clinical trials fail to meet enrollment timelines, approximately 30% never recruit a single participant (Telehealth and Medicine Today), and dropout rates range from 15–40% after enrollment (Applied Clinical Trials), adding months to development timelines and millions to trial costs.

The root causes are consistent across therapeutic areas: logistical burden on patients (travel, time commitment, complex visit schedules), poor communication and consent processes, lack of awareness that trials exist, and insufficient ongoing engagement after enrollment. Addressing these requires a shift from site-centric to patient-centric trial design — combining digital outreach, decentralized participation options, simplified consent, proactive retention workflows, and caregiver engagement. This guide covers 10 evidence-backed strategies that sponsors and CROs are using to improve both recruitment and retention.

Adopt a Patient-Centric Approach in Trial Design and Execution

A patient-centric approach makes clinical trials more accessible and engaging. To improve recruitment and retention, focus on:

• Understanding Patient Needs: Consider their daily challenges, medical conditions, and lifestyle.
• Reducing Barriers to Participation: Minimize travel, offer remote options, and simplify procedures.
• Enhancing Patient Experience: Provide clear communication, flexible scheduling, and personalized support.
• Involving Patients in Trial Design: Work with patient advocacy groups to ensure the study aligns with real-world needs.

By prioritizing the patient voice, trials become more relevant, leading to higher enrollment and retention rates.

Leverage Technology and Digital Platforms

Technology makes patient recruitment and retention more efficient by meeting patients where they are—online.

• Expand Reach: Use social media, targeted ads, and online registries to attract participants.
• Enhance Engagement: Leverage email campaigns, mobile apps, and telemedicine for ongoing communication.
• Improve Retention: Utilize ePRO, wearable devices, and digital reminders to track progress and support patients.

With over 3.5 billion social media users, digital outreach is a powerful tool to boost trial participation and ensure study completion.

For a broader view of how technology centralizes trial operations — from site management to regulatory workflows and budget oversight, see our complete guide to clinical trial management systems.

Prioritize Clear and Transparent Communication

Effective communication builds trust and improves both patient recruitment and retention.

• Simplify Informed Consent: Many consent forms are written at a 12th-grade level, while the average adult reads at an 8th-grade level, leading to confusion. Studies show that for each additional grade level increase in readability complexity, dropout rates rise by 16%.
• Set Clear Expectations: Outline trial details, benefits, risks, and commitments upfront.
• Address Concerns Proactively: Foster open communication and provide ongoing support.

When patients feel well-informed and confident, they are more likely to enroll and stay engaged throughout the trial.

Meet Patients Where They Are-Online and Offline

Reaching patients effectively requires a strategic outreach plan that engages them in both digital and real-world spaces.

• Online Engagement: Utilize social media platforms, patient communities, and targeted digital outreach to connect with potential participants.
• Community Partnerships: Collaborate with patient organizations, advocates, and local healthcare providers to build trust and credibility.
• In-Person Outreach: Host informational sessions at clinics, hospitals, and community centers to educate and engage patients.

By meeting patients where they already are, both online and offline, trials can increase awareness, recruitment, and long-term participation.

Address Logistical Barriers and Provide Support

Logistical challenges like transportation, financial constraints, and time commitments can discourage participation in clinical trials. To minimize burden and improve retention, consider:

• Covering Travel Costs: Offer transportation support, stipends, or reimbursement for study visits.
• Flexible Scheduling: Provide weekend, evening, or remote visit options to accommodate patients' availability.
• Reducing Site Visits: Use remote participation, telemedicine, and point-of-care testing (POCT) to limit unnecessary travel.
• Providing Compensation: Offer incentives for time and effort, helping ease financial concerns.

By removing logistical barriers, trials become more accessible, leading to higher recruitment and retention rates.

Don’t Forget Families and Care Partners

For many patients, care partners and family members play a crucial role in decision-making and ongoing participation.

• Engage Care Partners Early: Recruitment materials should address both patients and their loved ones, especially for conditions requiring caregiver support.
• Provide Family-Friendly Resources: Offer educational materials to help them understand the trial process and expectations.
• Train Site Staff: Ensure teams are prepared to answer caregiver concerns and provide ongoing support.

By supporting families and care partners, trials can improve enrollment, retention, and overall patient experience.

Provide Incentives and Show Appreciation

Recognizing and rewarding participants helps boost both recruitment and retention in clinical trials.

• Offer Meaningful Incentives: Provide compensation, travel reimbursement, and flexible participation options to ease burdens.
• Highlight the Impact: Emphasize altruism and contributions to medical research, reinforcing the value of their participation.
• Show Appreciation: Use thank-you notes, milestone achievement cards, and regular updates to keep participants engaged.
• Celebrate Milestones: Recognize study progress and participant dedication to foster motivation and long-term commitment.

By making patients feel valued, trials can improve engagement, satisfaction, and retention rates.

Build Relationships with Patient Organizations and Clinicians

Strong partnerships with patient advocacy groups and healthcare providers can enhance recruitment and retention efforts.

• Engage Patient Advocacy Groups: Work with patient organizations to understand participant needs and tailor outreach strategies.
• Leverage Trusted Physicians: Clinicians can refer eligible patients, increasing trust and trial enrollment.
• Create Referral Programs: Develop collaborations with research networks and patient registries to streamline recruitment.
• Start Early: Build long-term relationships with advocacy groups and providers before launching a study.

By partnering with trusted sources, trials gain credibility, wider reach, and improved patient retention.

Create a Feedback Loop and Listen to Patient Sentiment

Regular patient feedback helps improve the trial experience and boost retention rates.

• Use Surveys & Check-Ins: Collect feedback after site visits, mid-trial, and post-study to identify concerns early.
• Address Issues Promptly: Act on feedback to resolve communication gaps and logistical challenges.
• Leverage Sentiment Analysis: Use insights management tools to track patient sentiment and improve engagement.

By listening to participants, trials can enhance patient satisfaction, trust, and long-term commitment.

Stay Top-of-Mind and Offer Reminders

Consistent follow-up communication helps improve enrollment and retention by keeping patients engaged.

• Reach Out to Unresponsive Patients: A simple follow-up call or email can encourage enrollment.
• Send Timely Reminders: Use text messages, phone calls, or emails for appointment reminders and study updates.
• Leverage Retargeting: Digital ads and automated messages can re-engage interested participants.

By helping patients manage their schedules, trials can reduce dropouts and improve completion rates.

How Zelthy’s Decentralized Trial Management Solution Improves Recruitment and Retention

A decentralized trial management system removes barriers that hinder patient enrollment and retention, making trials more efficient, patient-friendly, and scalable. Zelthy’s Decentralized Trial Management Solution helps implement these strategies effectively:

✅ Make Trials More Accessible: Enable remote participation, home-based monitoring, and wearable device integration, reducing travel and time commitments for patients.

✅ Expand Recruitment Reach: Leverage targeted digital outreach, online registries, and social media integration to attract a wider and more diverse patient pool.

✅ Improve Communication and Trust: Offer automated trial updates, multimedia-informed consent, and real-time patient support, ensuring transparency and engagement.

✅ Reduce Dropout Rates with Automation: Use automated reminders, mobile-friendly patient portals, and AI-powered insights to keep participants informed and committed.

✅ Simplify Coordination with Healthcare Providers: Connect seamlessly with patient organizations, advocacy groups, and clinicians to enhance recruitment and study management.

Zelthy’s decentralized trial platform enables sponsors and CROs to streamline operations, improve patient experiences, and ensure trial success. By reducing logistical barriers and automating engagement, clinical trials become more efficient, cost-effective, and accessible.

For advanced and specialty therapies where patient coordination is especially complex, Zelthy's advanced therapy orchestration platform extends these recruitment capabilities into the full vein-to-vein lifecycle, from referral through manufacturing, logistics, and long-term follow-up.

Conclusion

A patient-centric approach is key to running successful trials with improved outcomes and higher retention. By leveraging technology, clear communication, logistical support, and patient engagement strategies, researchers can create a more efficient and cost-effective trial process.

Collaboration with patients, advocacy groups, and clinicians ensures trials are both accessible and impactful. As clinical research evolves, prioritizing patient needs and experiences will lead to more effective, scientifically robust, and patient-friendly trials.

Book a demo with us today and find out how we can help you run more efficient, patient-centric trials. Contact us at connect@zelthy.com or reach out to us on LinkedIn.

Frequently Asked Questions

Why do clinical trials struggle with patient recruitment?

Nearly 80% of clinical trials fail to meet enrollment timelines, and approximately 30% never recruit a single participant. The root causes are consistent: logistical burden on patients (travel, visit schedules, time commitment), poor awareness that trials exist, and consent processes written at reading levels above most adults. Precision medicine trials that require biomarker-defined patient subpopulations face additional challenges as eligible pools shrink — making structured, patient-centric recruitment strategies essential rather than optional.

What is a patient-centric approach to clinical trial design?

A patient-centric trial design minimizes participation burden by building the study around patient needs rather than site convenience. This includes reducing unnecessary site visits through remote participation options, simplifying consent forms to appropriate reading levels, offering flexible scheduling and travel compensation, and involving patient advocacy groups in protocol development. Trials designed with patient input consistently show higher enrollment rates and lower dropout rates than investigator-driven designs.

How does decentralized trial design improve recruitment?

Decentralized clinical trials (DCTs) expand the eligible patient pool by enabling participation from home through remote visits, ePRO data collection, wearable devices, and direct-to-patient drug delivery. This removes the geographic barrier that excludes patients who live far from research sites — a significant constraint for rare disease trials. DCTs also reduce per-patient visit burden, which lowers dropout rates after enrollment. Between 2012 and 2022, decentralized trial adoption grew over 400%, driven by demonstrated improvements in both recruitment speed and retention.

What is informed consent readability and why does it affect trial dropout?

Informed consent readability refers to the complexity level at which trial consent documents are written. Most consent forms are written at a 12th-grade reading level, while the average adult reads at an 8th-grade level. Research shows that for each additional grade level increase in readability complexity, dropout rates rise by 16%. Simplifying consent documents through plain language, visual aids, and multimedia formats improves patient comprehension, reduces anxiety-driven withdrawals, and strengthens the ethical foundation of the trial.

How can digital outreach improve clinical trial awareness?

Digital outreach through social media, targeted advertising, and patient community platforms significantly expands trial awareness beyond traditional physician referral networks. With over 3.5 billion social media users globally, digital channels enable sponsors to reach patients who self-identify with a diagnosis before an investigator refers them. Patient registries, disease-specific forums, and healthcare platform partnerships complement paid digital outreach — together enabling faster enrollment in geographically dispersed populations.

What incentives are appropriate for clinical trial participants?

Appropriate participant incentives include travel reimbursement, compensation for time and inconvenience, and logistical support such as childcare or accommodation near study sites. US regulations and IRB guidance permit compensation that reflects the burden of participation without constituting undue inducement. Beyond financial incentives, participants respond strongly to altruistic framing — being shown the direct contribution their participation makes to medical research — and to milestone recognition that acknowledges their commitment throughout the study.

What is the role of care partners in clinical trial retention?

Care partners — family members or designated caregivers — significantly influence whether patients complete clinical trials, particularly for chronic disease or oncology studies. Trials that fail to engage care partners in recruitment materials, consent processes, and ongoing communication see higher dropout rates when patients face barriers they cannot manage alone. Providing family-friendly resources, training site staff to address caregiver concerns, and offering flexible participation options that accommodate carer schedules all measurably improve long-term retention.